ANTI-TUMOUR NECROSIS FACTOR THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS DOES NOT ATTENUATE CUTANEOUS TUMOUR NECROSIS FACTOR ACTIVITY FOLLOWING A TUBERCULIN SKIN TEST

被引：0
|
作者：
Byng-Maddick, Rachel [1 ]
Haas, Carolin [1 ]
Ehrenstein, Michael [2 ]
Noursadeghi, Mahdad [1 ]
机构：
[1] UCL, Infect & Immun, London, England
[2] UCL, Med, London, England
来源：
RHEUMATOLOGY | 2016年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
208
引用
收藏
页码：146 / 146
页数：1
相关论文
共 50 条
  • [1] The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis
    Askling, Johan
    Dixon, Will
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (02) : 138 - 144
  • [2] Impact of anti-tumour necrosis factor therapy on the weight of patients with rheumatoid arthritis
    Alcorn, Nicola
    Tierney, Ann
    Wu, Olivia
    Gilmour, Harper
    Madhok, Rajan
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (08) : 1571 - 1571
  • [3] Anti-tumour necrosis factor a therapy in rheumatoid arthritis: an update on safety
    Hyrich, KL
    Silman, AJ
    Watson, KD
    Symmons, DPM
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (12) : 1538 - 1543
  • [4] Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis
    Leandro, Maria J.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2009, 11 (05)
  • [5] Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis
    Maria J Leandro
    [J]. Arthritis Research & Therapy, 11
  • [6] The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor
    Harrold, Leslie R.
    Reed, George W.
    Kremer, Joel M.
    Curtis, Jeffrey R.
    Solomon, Daniel H.
    Hochberg, Marc C.
    Greenberg, Jeffrey D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (02) : 430 - 436
  • [7] Anti-tumour necrosis factor α therapy modulates ghrelin in patients with severe rheumatoid arthritis
    Gonzalez-Gay, M. A.
    Garcia-Unzueta, M. T.
    Berja, A.
    Vazquez-Rodriguez, T. R.
    Gonzalez-Juanatey, C.
    de Matias, J. M.
    Martin, J.
    Dessein, P. H.
    Llorca, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (11) : 1644 - 1646
  • [8] DRUG SURVIVAL OF SECOND BIOLOGIC DMARD THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS: COMPARISON OF A SECOND ANTI-TUMOUR NECROSIS FACTOR WITH A SECOND NON-ANTI-TUMOUR NECROSIS FACTOR AFTER DISCONTINUATION OF A FIRST ANTI-TUMOUR NECROSIS FACTOR
    Wilke, Thomas
    Mueller, Sabrina
    Majer, Istvan
    Heisen, Marieke
    Fuchs, Andreas
    Maywald, Ulf
    [J]. RHEUMATOLOGY, 2016, 55 : 105 - 105
  • [9] Anti-tumour necrosis factor therapy associated with cutaneous vasculitis
    Livermore, PA
    Murray, KJ
    [J]. RHEUMATOLOGY, 2002, 41 (12) : 1450 - 1452
  • [10] Immunogenicity of anti-tumour necrosis factor therapy in Korean patients with rheumatoid arthritis and ankylosing spondylitis
    Jung, Seung Min
    Kim, Hyun-Sook
    Kim, Hae-Rim
    Kim, Na Young
    Lee, Jung-Hwa
    Kim, Juryun
    Kwok, Seung-Ki
    Park, Kyung-Su
    Park, Sung-Hwan
    Kim, Ho-Youn
    Ju, Ji Hyeon
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2014, 21 (01) : 20 - 25
12345